Literature DB >> 28317453

Ebola virus - epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans - an update on its 40 year's journey.

Raj Kumar Singh1, Kuldeep Dhama2, Yashpal Singh Malik3, Muthannan Andavar Ramakrishnan4, Kumaragurubaran Karthik5, Rekha Khandia6, Ruchi Tiwari7, Ashok Munjal6, Mani Saminathan2, Swati Sachan8, Perumal Arumugam Desingu2, Jobin Jose Kattoor3, Hafiz M N Iqbal9, Sunil Kumar Joshi10.   

Abstract

Ebola virus (EBOV) is an extremely contagious pathogen and causes lethal hemorrhagic fever disease in man and animals. The recently occurred Ebola virus disease (EVD) outbreaks in the West African countries have categorized it as an international health concern. For the virus maintenance and transmission, the non-human primates and reservoir hosts like fruit bats have played a vital role. For curbing the disease timely, we need effective therapeutics/prophylactics, however, in the absence of any approved vaccine, timely diagnosis and monitoring of EBOV remains of utmost importance. The technologically advanced vaccines like a viral-vectored vaccine, DNA vaccine and virus-like particles are underway for testing against EBOV. In the absence of any effective control measure, the adaptation of high standards of biosecurity measures, strict sanitary and hygienic practices, strengthening of surveillance and monitoring systems, imposing appropriate quarantine checks and vigilance on trade, transport, and movement of visitors from EVD endemic countries remains the answer of choice for tackling the EBOV spread. Herein, we converse with the current scenario of EBOV giving due emphasis on animal and veterinary perspectives along with advances in diagnosis and control strategies to be adopted, lessons learned from the recent outbreaks and the global preparedness plans. To retrieve the evolutionary information, we have analyzed a total of 56 genome sequences of various EBOV species submitted between 1976 and 2016 in public databases.

Entities:  

Keywords:  Ebola hemorrhagic fever; Ebola virus; carriers; control; diagnosis; epidemiology; preparedness; public health; transmission; treatment; vaccines

Mesh:

Substances:

Year:  2017        PMID: 28317453     DOI: 10.1080/01652176.2017.1309474

Source DB:  PubMed          Journal:  Vet Q        ISSN: 0165-2176            Impact factor:   3.320


  10 in total

1.  A Comparative NLP-Based Study on the Current Trends and Future Directions in COVID-19 Research.

Authors:  Priyankar Bose; Satyaki Roy; Preetam Ghosh
Journal:  IEEE Access       Date:  2021-05-20       Impact factor: 3.367

Review 2.  Advances in Diagnosis, Surveillance, and Monitoring of Zika Virus: An Update.

Authors:  Raj K Singh; Kuldeep Dhama; Kumaragurubaran Karthik; Ruchi Tiwari; Rekha Khandia; Ashok Munjal; Hafiz M N Iqbal; Yashpal S Malik; Rubén Bueno-Marí
Journal:  Front Microbiol       Date:  2018-01-19       Impact factor: 5.640

Review 3.  Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies - a comprehensive review.

Authors:  Raj Kumar Singh; Kuldeep Dhama; Sandip Chakraborty; Ruchi Tiwari; Senthilkumar Natesan; Rekha Khandia; Ashok Munjal; Kranti Suresh Vora; Shyma K Latheef; Kumaragurubaran Karthik; Yashpal Singh Malik; Rajendra Singh; Wanpen Chaicumpa; Devendra T Mourya
Journal:  Vet Q       Date:  2019-12       Impact factor: 3.320

Review 4.  Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments.

Authors:  Yashpal Singh Malik; Shubhankar Sircar; Sudipta Bhat; Khan Sharun; Kuldeep Dhama; Maryam Dadar; Ruchi Tiwari; Wanpen Chaicumpa
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

5.  The Veterinary Quarterly now ranked a top 10 journal in the Veterinary Science 2018 JCR.

Authors:  J H Han Van Der Kolk; Merran Govendir
Journal:  Vet Q       Date:  2019-12       Impact factor: 3.320

Review 6.  Transchromosomic bovines-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1, and influenza A virus.

Authors:  AbdulRahman A Saied; Manuela Sales Lima Nascimento; Adriano Henrique do Nascimento Rangel; Krzysztof Skowron; Katarzyna Grudlewska-Buda; Kuldeep Dhama; Jaffer Shah; Ahmed Abdeen; Fouad S El-Mayet; Hassan Ahmed; Asmaa A Metwally
Journal:  J Med Virol       Date:  2022-06-11       Impact factor: 20.693

Review 7.  Prevention and Control Strategies to Counter Zika Virus, a Special Focus on Intervention Approaches against Vector Mosquitoes-Current Updates.

Authors:  Raj K Singh; Kuldeep Dhama; Rekha Khandia; Ashok Munjal; Kumaragurubaran Karthik; Ruchi Tiwari; Sandip Chakraborty; Yashpal S Malik; Rubén Bueno-Marí
Journal:  Front Microbiol       Date:  2018-02-08       Impact factor: 6.064

Review 8.  SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.

Authors:  Ali A Rabaan; Shamsah H Al-Ahmed; Ranjit Sah; Ruchi Tiwari; Mohd Iqbal Yatoo; Shailesh Kumar Patel; Mamta Pathak; Yashpal Singh Malik; Kuldeep Dhama; Karam Pal Singh; D Katterine Bonilla-Aldana; Shafiul Haque; Dayron F Martinez-Pulgarin; Alfonso J Rodriguez-Morales; Hakan Leblebicioglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-09-02       Impact factor: 3.944

Review 9.  Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.

Authors:  Kuldeep Dhama; Kumaragurubaran Karthik; Rekha Khandia; Sandip Chakraborty; Ashok Munjal; Shyma K Latheef; Deepak Kumar; Muthannan Andavar Ramakrishnan; Yashpal Singh Malik; Rajendra Singh; Satya Veer Singh Malik; Raj Kumar Singh; Wanpen Chaicumpa
Journal:  Front Immunol       Date:  2018-08-10       Impact factor: 7.561

10.  An Investigation of the Effect of Transfected Defective, Ebola Virus Genomes on Ebola Replication.

Authors:  Sophie J Smither; Isabel Garcia-Dorival; Lin Eastaugh; James S Findlay; Lyn M O'Brien; Jonathan Carruthers; E Diane Williamson; Carmen Molina-París; Julian A Hiscox; Thomas R Laws
Journal:  Front Cell Infect Microbiol       Date:  2020-04-21       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.